GlassScriptPhysician profile
Amanda C Rainwater
NPI 1083637359
$1,683.93
in general payments reported to CMS, 2019-2025
21 companies · $562 in 2025
The $562 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2021: $126 · 2022: $120 · 2023: $86.08 · 2024: $507 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $236.78 | 2023-2025 | |
| Abbvie INC. | $163.06 | 2019-2025 | |
| Organon LLC | $132.75 | 2025 | Vtama |
| Celgene Corporation | $124.95 | 2019 | |
| Amgen INC. | $120.06 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $111.01 | 2019-2021 | |
| Ucb, INC. | $79.61 | 2024-2025 | Bimzelx |
| Dermavant Sciences, INC. | $78.94 | 2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $74.50 | 2024-2025 | |
| Leo Pharma INC. | $72.43 | 2024-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $69.29 | 2023-2024 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $68.67 | 2024-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $67.48 | 2025 | |
| Janssen Biotech, INC. | $60.68 | 2024-2025 | Tremfya, Simponi, Simponi Aria |
| Stemline Therapeutics INC. | $57.11 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $48.92 | 2024-2025 | Ebglyss, Taltz |
| Botanix Sb INC | $47.46 | 2025 | Sofdra |
| Pfizer INC. | $21.29 | 2025 | |
| Almirall LLC | $17.88 | 2025 | Klisyri |
| Incyte Corporation | $15.55 | 2025 | Opzelura |
| Strata Skin Sciences, INC. | $15.51 | 2024 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Rainwater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.